FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
FDA approves opiate-alternative acute pain management drug, local experts share their thoughts
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
clinicaladvisor.com4d
Astronauts Experience Acute and Chronic Pain During and After Spaceflight
Researchers assessed physiologic changes of the spine as well as the frequency of low back pain among astronauts during and after spaceflight.
Two biomarkers in the brain could transform how chronic pain is understood and managed
In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
TheHealthSite1h
The Connection Between Leprosy And Chronic Pain: A Neurological Insight
It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.
Managed Healthcare Executive1d
FDA Approves Journavx, New Nonopioid Med, for Acute Pain
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...
FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to ...
clinicalpainadvisor.com1d
Chronic Postoperative Pain Remains Common Despite Multimodal Analgesia
Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.
FDA approves new pain drug Journavx as opioid alternative
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
News Medical on MSN4d
New brain biomarker identifies pain sensitivity and may predict chronic pain risk
A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...
Business Wire2d
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigin ...